Investor Presentaiton
CRLS Key Business Updates (Cont'd)
Site Management ("SMO")
.
As of June 30, 2023, we had 1,776 ongoing site management projects and completed 105 site management projects
As of June 30, 2023, we had over 2,800 Clinical Research Coordinators ("CRC"s), covering more than 140 cities across China
Provided SMO services to 11 Class I innovative drug approvals in China in 1H2023
Clinical Trial Sites of Excellence ("E-Site")
As of June 30, 2023, our Excellence for Clinical Trial Sites ("E-Site") Program had 204 core collaborative sites and 61 green channel sites across
China, completed the signing of 39 strategic cooperation sites and the establishment of 6 co-sites, forming a diversified and win-win strategic
cooperation model
As of June 30, 2023, 17 full-time on-site staff were deployed to strategic collaboration sites in Beijing, Shanghai, Jiangsu, Zhejiang, Hunan, Hubei,
Shandong, Fujian, Chongqing, and Anhui, assisting the sites in efficiently managing and operating clinical projects, deepening the collaboration
with the sites, and jointly accelerating drug research and development efficiency
We started to provide new services including GCP qualification application and filing support, project bidding and import process support and
project initiation process optimization to our E-Site partners.
ā Tigermed
22
22View entire presentation